TECH BUYER Mar 2022 - IDC Perspective - Doc # US47235421

IDC Perspective: Real-World Evidence and Drug Pricing in 2022

By:

Nimita Limaye
Loading
,
Michael Townsend
Loading
Table of Contents

Executive Snapshot

Figure: Executive Snapshot: Real-World Evidence and Drug Pricing in 2022

Situation Overview

Examples of Innovative Value-Based Pricing Strategies

Challenges Associated with Value-Based Pricing

Conclusion

Advice for the Technology Buyer

Learn More

Related Research

Synopsis

Content


Related Links